Latest Content

Discover how advanced diagnostic tools enhance the accuracy of dementia assessments, leading to better treatment strategies and patient outcomes.

Explore the complexities of moral injuries in the Mideast conflict and their impact on mental health during a historic ceasefire.

New analysis reveals Ingrezza's 40 mg dose significantly improves tardive dyskinesia symptoms, showcasing long-term efficacy and safety in patients.

A recent study reveals that the choice of initial antipsychotic significantly impacts long-term weight gain, highlighting the complexity of treatment outcomes.

Explore the psychological impacts of the Israel-Palestine conflict, emphasizing trauma, identity, and the potential for healing and peace through psychiatry.

Explore the critical role of social determinants in mental health, highlighting their impact on wellbeing and the need for interdisciplinary research.

Creative individuals navigate the fine line between solitude and loneliness, discovering how isolation can fuel artistic expression or lead to despair.

Maximillian Fink, MD, a pioneering psychiatrist and advocate for ECT, leaves a lasting legacy in neuropsychiatry and education.

Uzedy, a once-monthly extended release long-acting injectable, is now FDA approved for bipolar I disorder.

New research reveals that benzodiazepines and antipsychotics increase mortality risk in hospice patients with Alzheimer disease and dementia.

A reproductive psychiatrist discusses the implications of recent FDA announcements on medication use during pregnancy, emphasizing the importance of mental health for mothers and babies.

Explore the complexities of aripiprazole in bipolar disorder treatment, including its efficacy and proper prescribing practices.